Literature DB >> 23449099

Loss of follow-up in orthopaedic trauma: is 80% follow-up still acceptable?

Boris A Zelle1, Mohit Bhandari, Alvaro I Sanchez, Christian Probst, Hans-Christoph Pape.   

Abstract

BACKGROUND: Loss of follow-up represents a potential source of bias. Suggested guidelines propose 20% loss of follow-up as acceptable. However, these guidelines have not been established through scientific investigations. The goal of this study was to evaluate how loss of follow-up influences the statistical significance in a trauma database.
METHODS: A database of 637 polytrauma patients with an average follow-up of 17.5 years postinjury was used. The functional outcome of workers' compensation patients versus nonworkers' compensation patients was compared using a validated scoring system. A significant difference between the 2 groups was found (P < 0.05). We simulated a gradually increasing loss of follow-up by randomly deleting an increasing number of patients from 2%, 5%, and 10%, and then increasing in increments of 5% until the significance changed. This process was repeated 50 times, each time with a different electronic random generator. For each simulation series, we documented at which simulated loss of follow-up that the results turned from significant (P < 0.05) to nonsignificant (P > 0.05).
RESULTS: Among 50 simulation series, the turning point from significant to nonsignificant varied between 15% and 75% loss of follow-up. A simulated loss of follow-up of 10% did not change the statistical significance in any of the simulation series; a simulated loss of follow-up of 20% changed the statistical significance in 28% of our simulation series.
CONCLUSIONS: A loss of follow-up of 20% or less may frequently change the study results. Researchers should establish protocols to minimize loss of follow-up and clearly state the loss of follow-up in manuscript publications.

Entities:  

Mesh:

Year:  2013        PMID: 23449099     DOI: 10.1097/BOT.0b013e31825cf367

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  27 in total

1.  Small Social Incentives Did Not Improve the Survey Response Rate of Patients Who Underwent Orthopaedic Surgery: A Randomized Trial.

Authors:  Hunter Warwick; Carolyn Hutyra; Cary Politzer; Andrew Francis; Thomas Risoli; Cynthia Green; Nikhil Verma; Scott Huettel; Richard C Mather
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

2.  Do Transsacral-transiliac Screws Across Uninjured Sacroiliac Joints Affect Pain and Functional Outcomes in Trauma Patients?

Authors:  John Heydemann; Braden Hartline; Mary Elizabeth Gibson; Catherine G Ambrose; John W Munz; Matthew Galpin; Timothy S Achor; Joshua L Gary
Journal:  Clin Orthop Relat Res       Date:  2016-06       Impact factor: 4.176

3.  Comparison of structural allograft and traditional autograft technique in occipitocervical fusion: radiological and clinical outcomes from a single institution.

Authors:  Jakub Godzik; Vijay M Ravindra; Wilson Z Ray; Meic H Schmidt; Erica F Bisson; Andrew T Dailey
Journal:  J Neurosurg Spine       Date:  2015-05-08

4.  Patients Who Undergo Early Aseptic Revision TKA Within 90 Days of Surgery Have a High Risk of Re-revision and Infection at 2 Years: A Large-database Study.

Authors:  Tony S Shen; Alex Gu; Patawut Bovonratwet; Nathaniel T Ondeck; Peter K Sculco; Edwin P Su
Journal:  Clin Orthop Relat Res       Date:  2022-03-01       Impact factor: 4.755

5.  Oral methotrexate at doses 15-25 mg/week is non-inferior to parenteral regarding efficacy and safety in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Fang Wang; Jingliang Tang; Zhe Li; Yanyan Qi; Ganpeng Li; Fang Wang
Journal:  Clin Rheumatol       Date:  2022-06-07       Impact factor: 3.650

6.  Lost to follow-up: reasons and outcomes following tibial plateau fractures.

Authors:  Martin F Hoffmann; Debra L Sietsema; Clifford B Jones
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-07-21

Review 7.  Loss to follow-up in orthopaedic clinical trials: a systematic review.

Authors:  Jeremy S Somerson; Katherine C Bartush; Jeffrey B Shroff; Mohit Bhandari; Boris A Zelle
Journal:  Int Orthop       Date:  2016-05-03       Impact factor: 3.075

8.  Predicting and Preventing Loss to Follow-up of Adult Trauma Patients in Randomized Controlled Trials: An Example from the FLOW Trial.

Authors:  Kim Madden; Taryn Scott; Paula McKay; Brad A Petrisor; Kyle J Jeray; Stephanie L Tanner; Mohit Bhandari; Sheila Sprague
Journal:  J Bone Joint Surg Am       Date:  2017-07-05       Impact factor: 5.284

9.  Cochrane in CORR®: Strategies to Improve Recruitment to Randomised Trials.

Authors:  Kim Madden; Mohit Bhandari
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

10.  Cochrane in CORR: Strategies to Improve Retention in Randomised Trials.

Authors:  Kim Madden; Sheila Sprague
Journal:  Clin Orthop Relat Res       Date:  2022-01-01       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.